Michael Z Leonard1, Joseph F DeBold1, Klaus A Miczek2,3. 1. Department of Psychology, Tufts University, Medford, MA, USA. 2. Department of Psychology, Tufts University, Medford, MA, USA. Klaus.Miczek@tufts.edu. 3. Department of Neuroscience, Tufts University, Boston, MA, USA. Klaus.Miczek@tufts.edu.
Abstract
RATIONALE: Exposure to intermittent social defeat stress elicits corticotropin releasing factor (CRF) release into the VTA and induces long-term modulation of mesocorticolimbic dopamine activity in rats. These adaptations are associated with an intense cocaine-taking phenotype, which is prevented by CRF receptor antagonists. OBJECTIVE: The present studies examine whether infusion of CRF into the VTA is sufficient to escalate cocaine-taking behavior, in the absence of social defeat experience. Additionally, we aimed to characterize changes in cocaine valuation that may promote binge-like cocaine intake. METHODS: Male Long-Evans rats were microinjected into the VTA with CRF (50 or 500 ng/side), vehicle, or subjected to social defeat stress, intermittently over 10 days. Animals were then trained to self-administer IV cocaine (FR5). Economic demand for cocaine was evaluated using a within-session behavioral-economics threshold procedure, which was followed by a 24-h extended access "binge." RESULTS: Rats that experienced social defeat or received intra-VTA CRF microinfusions (50 ng) both took significantly more cocaine than controls over the 24-h binge but showed distinct patterns of intake. Behavioral economic analysis revealed that individual demand for cocaine strongly predicts binge-like consumption, and demand elasticity (i.e. α) is augmented by intra-VTA CRF, but not by social defeat. The effects of CRF on cocaine-taking were also prevented by intra-VTA pretreatment with CP376395, but not Astressin-2B. CONCLUSIONS: Repeated infusion of CRF into the VTA persistently alters cocaine valuation and intensifies binge-like drug intake in a CRF-R1-dependent manner. Conversely, the persistent pattern of cocaine bingeing induced by social defeat stress may suggest impaired inhibitory control, independent of reward valuation.
RATIONALE: Exposure to intermittent social defeat stress elicits corticotropin releasing factor (CRF) release into the VTA and induces long-term modulation of mesocorticolimbic dopamine activity in rats. These adaptations are associated with an intense cocaine-taking phenotype, which is prevented by CRF receptor antagonists. OBJECTIVE: The present studies examine whether infusion of CRF into the VTA is sufficient to escalate cocaine-taking behavior, in the absence of social defeat experience. Additionally, we aimed to characterize changes in cocaine valuation that may promote binge-like cocaine intake. METHODS: Male Long-Evans rats were microinjected into the VTA with CRF (50 or 500 ng/side), vehicle, or subjected to social defeat stress, intermittently over 10 days. Animals were then trained to self-administer IV cocaine (FR5). Economic demand for cocaine was evaluated using a within-session behavioral-economics threshold procedure, which was followed by a 24-h extended access "binge." RESULTS:Rats that experienced social defeat or received intra-VTA CRF microinfusions (50 ng) both took significantly more cocaine than controls over the 24-h binge but showed distinct patterns of intake. Behavioral economic analysis revealed that individual demand for cocaine strongly predicts binge-like consumption, and demand elasticity (i.e. α) is augmented by intra-VTA CRF, but not by social defeat. The effects of CRF on cocaine-taking were also prevented by intra-VTA pretreatment with CP376395, but not Astressin-2B. CONCLUSIONS: Repeated infusion of CRF into the VTA persistently alters cocaine valuation and intensifies binge-like drug intake in a CRF-R1-dependent manner. Conversely, the persistent pattern of cocaine bingeing induced by social defeat stress may suggest impaired inhibitory control, independent of reward valuation.
Entities:
Keywords:
Behavioral economics; Cocaine; Corticotropin releasing factor (CRF); Self-administration; Social defeat stress; Ventral tegmental area (VTA)
Authors: Chesley J Christensen; Alan Silberberg; Steven R Hursh; Mary E Huntsberry; Anthony L Riley Journal: Psychopharmacology (Berl) Date: 2008-03-20 Impact factor: 4.530
Authors: David Y Lee; Matthew Guttilla; Kinsun D Fung; Stacey McFeron; Jerry Yan; Robert Ranaldi Journal: Pharmacol Biochem Behav Date: 2007-01-23 Impact factor: 3.533
Authors: A Bifone; A Gozzi; A Cippitelli; A Matzeu; E Domi; H Li; G Scuppa; N Cannella; M Ubaldi; F Weiss; R Ciccocioppo Journal: Addict Biol Date: 2018-10-17 Impact factor: 4.280
Authors: Sarah E Daniel; Aurélie Menigoz; Jidong Guo; Steven J Ryan; Shivani Seth; Donald G Rainnie Journal: Neuropharmacology Date: 2019-03-14 Impact factor: 5.250
Authors: Michael Z Leonard; Paul Rostin; Kevin P Hill; Stephanie D Grabitz; Matthias Eikermann; Klaus A Miczek Journal: Int J Neuropsychopharmacol Date: 2020-06-24 Impact factor: 5.176